Skip to main content

Bunker Kevin D.

Chief Scientific Officer | Chief Operating Officer

1 company

Insider Signal Score

78
Excellent
Trades Analyzed
34
12M Win Rate
88.2%
Avg 3M Return
+9.6%
Avg 12M Return
+42.9%

Bunker Kevin D. is a Chief Scientific Officer at Zentalis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 18 sells.

Estimated insider holdings value: $4.2M based on current market prices.

Holdings by Company

ZNTLDec 20, 2023
Current Shares834.9K
Value$4.17M
Net Activity-446,005
Bought: 350Sold: 446.4K

Transaction History

Showing 10 filings
DateTickerRoleTypeSharesPriceValueChg%3M12MSEC
Oct 4, 2023
ZNTL
Zentalis Pharmaceuticals, Inc.
Chief Scientific OfficerSell6,068$19.50$118,355.48-0.4%-19.7%-83.9%
May 26, 2023
ZNTL
Zentalis Pharmaceuticals, Inc.
Chief Scientific OfficerSell80,000$30.02$2,401,248.00-84.2%-16.1%-62.5%
Feb 14, 2023
ZNTL
Zentalis Pharmaceuticals, Inc.
Chief Scientific OfficerSell10,307$20.14$207,628.94-0.6%+39.7%-40.4%
Aug 10, 2022
ZNTL
Zentalis Pharmaceuticals, Inc.
Chief Operating OfficerSell5,000$30.00$150,000.00-5.0%-23.3%-13.0%
Jul 20, 2022
ZNTL
Zentalis Pharmaceuticals, Inc.
Chief Operating OfficerSell5,000$30.00$150,000.00-4.8%-22.7%-16.3%
Jul 14, 2022
ZNTL
Zentalis Pharmaceuticals, Inc.
Chief Operating OfficerSell5,000$30.01$150,062.10-2.3%-25.5%-6.3%
Jul 5, 2022
ZNTL
Zentalis Pharmaceuticals, Inc.
Chief Operating OfficerSell25,000$30.07$751,652.50-18.5%-27.6%-8.7%
Apr 11, 2022
ZNTL
Zentalis Pharmaceuticals, Inc.
Chief Operating OfficerSell5,000$30.55$152,744.90-1.2%-13.0%-43.7%
Mar 21, 2022
ZNTL
Zentalis Pharmaceuticals, Inc.
Chief Operating OfficerSell10,000$49.07$490,669.87-3.4%-51.1%-62.5%
Mar 10, 2022
ZNTL
Zentalis Pharmaceuticals, Inc.
Chief Operating OfficerSell10,000$46.94$469,374.23-2.1%-41.0%-65.5%
Page 1Next →